Laurent Bastit

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Laurent Bastit is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Laurent Bastit has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Hematology. Recurrent topics in Laurent Bastit's work include Bone health and treatments (5 papers), Erythropoietin and Anemia Treatment (5 papers) and Oral health in cancer treatment (5 papers). Laurent Bastit is often cited by papers focused on Bone health and treatments (5 papers), Erythropoietin and Anemia Treatment (5 papers) and Oral health in cancer treatment (5 papers). Laurent Bastit collaborates with scholars based in France, Hungary and Switzerland. Laurent Bastit's co-authors include Thierry Frébourg, Audrey Killian, Jean‐Christophe Sabourin, A M Queuniet, B Paillot, Richard Sesboüé, Frédéric Blanchard, Marie‐Pierre Galais, A. Lamy and F Michot and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Laurent Bastit

18 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

2007 621 citations Frédéric Di Fiore, Frédéric Blanchard et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Laurent Bastit

Since Specialization

Citations

This map shows the geographic impact of Laurent Bastit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Bastit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Bastit more than expected).

Fields of papers citing papers by Laurent Bastit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Bastit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Bastit. The network helps show where Laurent Bastit may publish in the future.

Co-authorship network of co-authors of Laurent Bastit

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Bastit. A scholar is included among the top collaborators of Laurent Bastit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Bastit. Laurent Bastit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Description des modalités pratiques de prescription d’un facteur de croissance de la lignée granulocytaire (G-CSF) chez les patientes recevant une chimiothérapie pour un cancer du sein : étude Opaline 2015 ·Bulletin du Cancer ·William Jacot, Éric-Charles Antoine, Maya Hacini, (unknown), Alain Rivière, Laurence Moureau-Zabotto, (unknown), (unknown), Hubert Orfeuvre, (unknown), (unknown), Laurent Bastit, (unknown), D. Azria	2
2	Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: Results of the CAVECCAS study. 2014 ·Journal of Clinical Oncology ·P. Debourdeau, Marc Espié, Joseph Gligorov, Antoine Élias, M.-A. Sevestre, Pierre‐François Dupré, (unknown), Sandrine Lavau‐Denès, Laurent Bastit, (unknown), Sylvie Chevret, Dominique Farge	1
3	Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient–nurse satisfaction 2013 ·Supportive Care in Cancer ·Thierry Lebrét, (unknown), Alain Lortholary, Claude El Kouri, Laurent Bastit, (unknown), (unknown), X. Murraciole, S. Guérif	3
4	Traitement à domicile par l’acide zolédronique chez des patients atteints de tumeurs solides : observance et satisfaction du patient et de l’infirmier 2013 ·Bulletin du Cancer ·Thierry Lebrét, (unknown), Alain Lortholary, Claude El Kouri, Laurent Bastit, (unknown), (unknown), X. Murraciole, S. Guérif	1
5	Home-Based Zoledronic Acid (ZOL) Infusion Therapy in Patients with Solid Tumours: Compliance and Patient-Nurse Satisfaction 2012 ·Annals of Oncology ·(unknown), (unknown), Alain Lortholary, Claude El Kouri, Laurent Bastit, (unknown), (unknown), Xavier Muracciole, S. Guérif	0
6	Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Joseph Gligorov, Laurent Bastit, (unknown), (unknown), (unknown), D. Lepillé, Élisabeth Luporsi, Giuseppe Sasso, C. Varette, D. Azria	27
7	Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study 2009 ·Breast Cancer Research and Treatment ·Karine Briot, M. Tubiana-Hulin, Laurent Bastit, Ioana Kloos, Christian Roux	91
8	Effects of switching aromatase inhibitors on arthralgia: the ATOLL study. 2009 ·Cancer Research ·Karine Briot, Laurent Bastit, (unknown), D. Spaëth, (unknown), Ioana Kloos, I. Bourdeix, (unknown)	6
9	French experience of patient management when receiving oral vinorelbine chemotherapy (NVBO) for metastatic breast cancer: Final results of a prospective observational survey on practices 2009 ·Journal of Clinical Oncology ·Jean‐Pierre Lotz, (unknown), (unknown), (unknown), Laurent Bastit, A. Riviére, Abou‐Bakr M. Youssef, (unknown), Stéphane Nahon, (unknown)	1
10	Intérêt d’un gel stérile anti-brûlure dans les radiodermites : résultats d’une étude comparative 2008 ·Annales de Dermatologie et de Vénéréologie ·(unknown), Sébastien Salas, (unknown), Laurent Bastit, M. Alfonsi, Gaëtan De Rauglaudre, (unknown), Clotilde Allavena, Charline Miot, J. Boisseau, (unknown)	15
11	Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia 2008 ·Journal of Clinical Oncology ·Laurent Bastit, A. Vandebroek, Sevilay Altıntaş, (unknown), Tamás Pintér, Tamás Sütö, (unknown), (unknown), (unknown)	157
12	Comparison of the efficacy and safety of miconazole 50‐mg mucoadhesive buccal tablets with miconazole 500‐mg gel in the treatment of oropharyngeal candidiasis 2007 ·Cancer ·(unknown), Jamel Daoud, B. El Gueddari, Laurent Bastit, (unknown), (unknown), (unknown), Philippe Céruse, G. Calais, P Attali	46
13	Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy breakdown → 2007 ·British Journal of Cancer ·Frédéric Di Fiore, Frédéric Blanchard, F. Charbonnier, Florence Le Pessot, A. Lamy, Marie‐Pierre Galais, Laurent Bastit, Audrey Killian, Richard Sesboüé, Jean‐Jacques Tuech, A M Queuniet, B Paillot, Jean‐Christophe Sabourin, F Michot, Pierre Michel, Thierry Frébourg	621
14	Randomized, Double-Blind, Active-Controlled Trial of Every-3-Week Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia 2006 ·JNCI Journal of the National Cancer Institute ·Jean-Luc Canon, Johan Vansteenkiste, G. Bodoky, María‐Victoria Mateos, Laurent Bastit, Irene Ferreira, Greg Rossi, Rafael G. Amado	83
15	A randomized open-label study of darbepoetin alfa administered every 3 weeks with or without parenteral iron in anemic subjects with nonmyeloid malignancies receiving chemotherapy 2006 ·Journal of Clinical Oncology ·A. Vandebroek, (unknown), Sevilay Altıntaş, (unknown), Baojin Yao, Marco Schupp, Laurent Bastit	7
16	Effect of Dose Reductions on Response to 500-μg Darbepoetin alfa Administered Once Every 3 Weeks for the Treatment of Chemotherapy-Induced Anemia: Analysis from a Randomized, Double-Blind, Active-Controlled Trial. 2005 ·Blood ·Jean-Luc Canon, Johan Vansteenkiste, G. Bodoky, (unknown), Laurent Bastit, Irene Ferreira, Tom Lillie	1
17	Final results of a randomized, double-blind, active-controlled trial of darbepoetin alfa administered once every 3 weeks (Q3W) for the treatment of anemia in patients receiving multicycle chemotherapy 2005 ·Journal of Clinical Oncology ·J.-L. Canon, Johan Vansteenkiste, G. Bodoky, María‐Victoria Mateos, Laurent Bastit, (unknown), Giuseppe Rossi	9
18	Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers 2001 ·International Journal of Radiation OncologyBiologyPhysics ·Laurent Bastit, Emmanuel Blot, P. Debourdeau, Jean-François Ménard, P Bastit, R. Le Fur	46
19	Traitement anticoagulant classique de la maladie thromboembolique veineuse chez les patients cancéreux. À propos d'une série rétrospective de 71 patients 1996 ·La Revue de Médecine Interne ·P. Debourdeau, Guy Meyer, (unknown), Zora Marjanovic, Laurent Bastit, J. Cabané, (unknown), J.M. Extra, Dominique Farge	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact